Global Intraosseous Infusion Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Intraosseous Infusion Devices Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Intraosseous Infusion Devices are medical devices that help infuse drugs, fluids or blood products directly into the bone marrow, for emergency situations. Intraosseous Infusion Devices offer the fastest way to quickly infuse needed medications and fluids in emergency situations.

Market Overview:

The latest research study on the global Intraosseous Infusion Devices market finds that the global Intraosseous Infusion Devices market reached a value of USD 431.7 million in 2022. It’s expected that the market will achieve USD 705.34 million by 2028, exhibiting a CAGR of 8.53% during the forecast period.

Market Drivers Analysis

Application of Intraosseous Infusion Devices in First Aid
In the emergency process, the establishment of a fast and effective infusion channel is the prerequisite for ensuring emergency medication. The key to successful rescue is to quickly establish infusion channels for critically ill patients in the emergency department and to quickly infuse fluids with medication. However, unforeseen problems are often encountered during first aid, such as: peripheral circulatory failure in a state of shock, venous collapse, or patient agitation that does not cooperate with the operation; ambulance bumps on the way, making the operation difficult; the scene is complicated and dangerous, or other conditions are limited etc., often delay the rescue time because of the inability to quickly establish an intravenous infusion channel. Bone marrow infusion is easy to identify because of the bone landmarks, and it can be operated in various postures and poor environmental conditions, with a high success rate. For example, emergency surgical critical illness is more common in the emergency department. Taking traffic accidents as an example, the wounded may have craniocerebral injury and chest and abdominal injury at the same time. Complex and critical injuries are often accompanied by shock. Infusion is an important means of anti-shock treatment, but the environment of venipuncture Strict requirements, high requirements for puncture technology, in some special patients such as severe burns, car accidents, explosion wounded, obese patients with edema, shock patients with poor vascular filling, critical patients with sudden cardiac arrest, etc. When there is no available blood vessel, it is difficult to quickly establish a reliable fluid pathway, leaving the healer in a dilemma. In this case, Intraosseous Infusion Devices are the best way to help establish emergency infusion access. In general, the application of Intraosseous Infusion Devices in emergency treatment is one of the driving factors driving the development of the industry.

Challenges Analysis

The popularity of Intraosseous Infusion Devices in some areas is not high
At present, in some areas, the intraosseous cavity infusion technology is still backward, and medical staff do not fully understand the technology and devices. For example, medical staff hold a wait-and-see attitude towards intraosseous infusion technology. The cognition of medical staff on infusion is still at the stage of intravenous administration, and it is difficult to accept the method of intraosseous infusion, and they are worried about the occurrence of complications after infusion, which makes the clinical implementation of intraosseous infusion not smooth. In addition, in terms of medical education, medical students have not learned the knowledge of intraosseous infusion during school, and most hospitals have no relevant training on intraosseous infusion. Still skeptical about the effect of intraosseous infusion, not even using the concept of Intraosseous Infusion Devices. These reasons lead to the low penetration rate of Intraosseous Infusion Devices in critically ill patients, less clinical use, and slower development. In most areas, the original manual bone puncture needle is used for bone puncture. Generally speaking, the low popularity of Intraosseous Infusion Devices in some areas is one of the important factors restricting the development of the industry.

Region Overview:

In 2022, the share of the Intraosseous Infusion Devices market in United States stood at 50.19% .

Company Overview:

Teleflex is a global medical technology provider that improves people's health and quality of life. The company's diverse product portfolio offers solutions in the areas of vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care. The company's brands include Arrow®, Deknatel®, LMA®, Pilling®, QuikClot®, Rüsch®, UroLift® and Weck®, among others. 2020, Teleflex Incorporated has announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to expand the Indications for Use of the Arrow® EZ-IO® Intraosseous Vascular Access System. This device can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases.

BD is one of the world's largest global medical technology companies, advancing a healthy world by improving medical discovery, diagnosis and care delivery. The company supports healthcare frontline heroes by developing innovative technologies, services and solutions that help advance clinical care for patients and clinical processes for healthcare providers. On June 22, 2022, BD announced a voluntary recall of the BD™ Intraosseous Needle Set, BD™ Intraosseous Manual Driver Set and BD™ Intraosseous Power Driver.

Teleflex is one of the major players operating in the Intraosseous Infusion Devices market, holding a share of 54.56% in 2023.

Segmentation Overview:

Manual
Differentiate according to the driving mode. Manual devices require the provider to twist the device by hand to pierce the skin, tissue, and bone for access to the bone marrow.
Automatic
Automatic devices include semi-automatic and automatic. This type of product is easy to operate and easy to puncture. Some products of this type are powered by batteries, and common brands on the market include FAST, BIG, etc.

By type, Manual segment accounted for the largest share of market in 2022.

Application Overview:

Mainly divide Hospitals and Ambulatory Surgical Centers according to different downstream institutions. In contrast to Hospitals, Ambulatory Surgical Centers focuses on providing same-day surgical care, including diagnostic and preventive procedures. Ambulatory surgery centers provide surgery without an overnight stay. ASCs provide cost-effective services and a convenient environment that is less stressful than what many hospitals can offer.

The market's largest segment by application is the segment Hospitals, with a market share of 74.06%in 2022.

Key Companies in the global Intraosseous Infusion Devices market covered in Chapter 3:

Cook Medical
SAM Medical
Biopsybell
Teleflex
PerSys Medical
BD

In Chapter 4 and Chapter 14.2, on the basis of types, the Intraosseous Infusion Devices market from 2018 to 2029 is primarily split into:

Manual
Automatic

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Intraosseous Infusion Devices market from 2018 to 2029 covers:

Hospitals
Ambulatory Surgical Centers
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)